Quercetin Induces Tumor-selective Apoptosis Through Downregulation of Mcl-1 and Activation of Bax
Overview
Authors
Affiliations
Purpose: To investigate the in vivo antitumor efficacy of quercetin in U937 xenografts and the functional roles of Mcl-1 and Bax in quercetin-induced apoptosis in human leukemia.
Experimental Design: Leukemia cells were treated with quercetin, after which apoptosis, Mcl-1 expression, and Bax activation and translocation were evaluated. The efficacy of quercetin as well as Mcl-1 expression and Bax activation were investigated in xenografts of U937 cells.
Results: Administration of quercetin caused pronounced apoptosis in both transformed and primary leukemia cells but not in normal blood peripheral mononuclear cells. Quercetin-induced apoptosis was accompanied by Mcl-1 downregulation and Bax conformational change and mitochondrial translocation that triggered cytochrome c release. Knockdown of Bax by siRNA reversed quercetin-induced apoptosis and abrogated the activation of caspase and apoptosis. Ectopic expression of Mcl-1 attenuated quercetin-mediated Bax activation, translocation, and cell death. Conversely, interruption of Mcl-1 by siRNA enhanced Bax activation and translocation, as well as lethality induced by quercetin. However, the absence of Bax had no effect on quercetin-mediated Mcl-1 downregulation. Furthermore, in vivo administration of quercetin attenuated tumor growth in U937 xenografts. The TUNEL-positive apoptotic cells in tumor sections increased in quercetin-treated mice as compared with controls. Mcl-1 downregulation and Bax activation were also observed in xenografts.
Conclusions: These data suggest that quercetin may be useful for the treatment of leukemia by preferentially inducing apoptosis in leukemia versus normal hematopoietic cells through a process involving Mcl-1 downregulation, which, in turn, potentiates Bax activation and mitochondrial translocation, culminating in apoptosis.
Lee E, Yang D, Hong J Antioxidants (Basel). 2025; 14(1).
PMID: 39857383 PMC: 11760868. DOI: 10.3390/antiox14010049.
Amrati F, Mssillou I, Boukhira S, Djiddi Bichara M, El Abdali Y, Galvao de Azevedo R Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931453 PMC: 11207108. DOI: 10.3390/ph17060786.
A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms.
Xiong F, Zhang Y, Li T, Tang Y, Song S, Zhou Q Front Pharmacol. 2024; 15:1389179.
PMID: 38855739 PMC: 11157233. DOI: 10.3389/fphar.2024.1389179.
Gu C, Tang L, Hao Y, Dong S, Shen J, Xie F J Cancer. 2023; 14(11):1956-1980.
PMID: 37497415 PMC: 10367918. DOI: 10.7150/jca.85517.
Germano C, Clemente G, Storniolo A, Romeo M, Ferretti E, Cirone M Biology (Basel). 2023; 12(5).
PMID: 37237490 PMC: 10215294. DOI: 10.3390/biology12050676.